GeneTether Therapeutics, Inc.'s total assets for Q3 2024 were $1.02M, a decrease of -8.02% from the previous quarter. TSE:GTTX total liabilities were $29.43K for the fiscal quarter, a 26.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.